T50.A11
Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional)
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by the pertussis vaccine, classified under ICD-10 code T50.A11, refers to unintentional adverse effects caused by the pertussis vaccine, including cases where it is combined with other vaccine components. This type of poisoning occurs when the vaccine is inadvertently administered in a manner that leads to harmful effects, or when adverse reactions happen despite proper administration. While vaccines are generally safe and effective, understanding potential complications is important for healthcare providers and patients alike.
Causes & Symptoms
Clinical Causes: Accidental overdose or incorrect dosage of the vaccine Administration of the vaccine by untrained or improperly trained personnel Use of contaminated vaccine or storage errors leading to vaccine degradation Unintentional injection into the bloodstream instead of muscle tissue Manufacturing defects or compromised vaccine formulations Patient allergy or hypersensitivity reactions to vaccine components Errors in reading or interpreting vaccine instructions
Key Symptoms: Localized swelling, redness, or pain at the injection site Fever or mild flu-like symptoms following vaccination Allergic reactions such as hives, rash, or itching Difficulty breathing or swelling of the face or throat Unusual drowsiness or irritability in infants and children Severe reactions like seizures or neurological symptoms (rare) Signs of infection at the injection site, such as pus or increased pain
Diagnostic & Treatment
Diagnosis Path: Diagnosing poisoning by the pertussis vaccine primarily involves reviewing the patient's vaccination history and clinical presentation. Healthcare providers may conduct additional tests to rule out other conditions and confirm adverse effects related to the vaccine. Blood tests, allergy testing, and assessment of the injection site may be part of the diagnostic process. Identifying the timing of symptom onset relative to vaccination is crucial for establishing a connection.
Treatment Protocols: Management of poisoning by the pertussis vaccine focuses on symptomatic relief and preventing complications. Immediate medical attention may be necessary in case of severe allergic reactions, including the use of epinephrine and other emergency interventions. Supportive care can include antihistamines, corticosteroids, and observation for adverse neurological or systemic effects. In some cases, hospitalization may be required for intensive monitoring and treatment. It's important to report adverse reactions to vaccine safety authorities to improve understanding and management of such events.
Clinical Advice & FAQs
Billing Guidance
Is T50.A11 a billable ICD-10 code?
Yes, T50.A11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T50.A11?
Clinical documentation must specify the nature of Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
